Results
Previous results
The Precision Nutrition laboratory is a leader in the use of personalized nutrition strategies for the modulation of metabolism.
NutriSi-ON is an interdisciplinary project in which two groups with complementary and synergistic skills and experiences work together to develop a new approach to precision nutrition in immunology.
The most relevant results associated with the program include scientific publications in the last 5 years.
Study to Childhood Obesity Prevention
The Chemokine Receptor CCR5
Intestinal Intervention Strategy Targeting Myeloid Cells to Improve Hepatic Immunity during Hepatocarcinoma Development.
Metabolic Health Together with a Lipid Genetic Risk Score Predicts Survival of Small Cell Lung Cancer Patients
Precision Nutrition to Activate Thermogenesis as a Complementary Approach to Target Obesity and Associated-Metabolic-Disorders. Cancers (Basel)
Precision Nutrition to Activate Thermogenesis as a Complementary Approach to Target Obesity and Associated-Metabolic-Disorders
Miracle Berry as a Potential Supplement in the Control of Metabolic Risk Factors in Cancer
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer
Saponin-Rich Extracts and Their Acid Hydrolysates Differentially Target Colorectal Cancer Metabolism in the Frame of Precision Nutrition
Non-Coding and Regulatory RNAs as Epigenetic Remodelers of Fatty Acid Homeostasis in Cancer
Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth
Dysfunctional oxidative phosphorylation shunts branched-chain amino acid catabolism onto lipogenesis in skeletal muscle
Marigold Supercritical Extract as Potential Co-adjuvant in Pancreatic Cancer: The Energetic Catastrophe Induced via BMP8B Ends Up With Autophagy-Induced Cell Death
Yarrow Supercritical Extract Ameliorates the Metabolic Stress in a Model of Obesity Induced by High-Fat Diet
Tolerability and Safety of a Nutritional Supplement with Potential as Adjuvant in Colorectal Cancer Therapy: A Randomized Trial in Healthy Volunteers
A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment
Deciphering the Human Gut Microbiome of Urolithin Metabotypes: Association with Enterotypes and Potential Cardiometabolic Health Implications
ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone
Association of calcium and dairy product consumption with childhood obesity and the presence of a Brain Derived Neurotropic Factor-Antisense (BDNF-AS) polymorphism
The gut microbiota urolithin metabotypes revisited: the human metabolism of ellagic acid is mainly determined by aging
The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance
The transcriptional and mutational landscapes of lipid metabolism-related genes in colon cancer
Novel Polyphenols That Inhibit Colon Cancer Cell Growth Affecting Cancer Cell Metabolism. J Pharmacol
Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs
MicroRNA-661 modulates redox and metabolic homeostasis in colon cancer.
Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells.
Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer
In the Precision Nutrition group, several doctoral theses have been defended in the last five years.
Lipchronic® as an antitumor and immunomodulatory agent in lung cancer
Identification of the molecular effect of bioactive compounds for the development of effective nutritional supplements in achieving healthy aging through precision nutrition
Analysis of the effect of bioactive compounds on cancer as personalized complementary agents
Formulations for personalized nutrition of cancer patients
Metabolic alterations in cancer and their effect on the epithelial-mesenchymal transition
In addition, two more theses are under development.
Study of bioactive compounds derived from Synsepalum dulcificum on the modulation of pathways involved in chronic diseases and their validation by Precision Nutrition
Clinical features and lipid metabolism genes as potential biomarkers in lung cancer
The group has also filed two related patents, both of which have been transferred to the industry.
Sistemas lípidos portadores de compuestos bioactivos. Organismos: Universidad Autónoma de Madrid, IMDEA Alimentación, Hospital Infanta Sofía
Composición para la reducción del declive metabólico asociado al envejecimiento y/o el tratamiento de trastornos relacionados al metabolismo lipídico
Scientific Publications
Participation in Congresses
Precision nutrition approaches for metabolic health and immune system modulation in cancer and chronic diseases. Cristina Mª Fernández*, Lara P. Fernández*, Gonzalo Colmenarejo, Isabel Espinosa-Salinas, Susana Molina, María Merino, Juan Moreno-Rubio, Enrique Casado, María Sereno and Ana Ramírez de Molina. 8th International Conference on Systems Biology of Mammalian Cells SBMC. Heidelberg May 16-18th 2022 “From Systems Medicine towards Digital Health”.
- METABOCANCER Meeting on Cellular and Systemic Interactions between Cancer and Metabolism. Madrid, Spain, 07-08/07/2022.
- 3rd Epigenetics: From Mechanisms to Disease Conference. Cancun, Mexico, 19-22 May, 2022
- New insights into metabolism and mitochondria. Centro de Biología Molecular Severo Ochoa (CBMSO), Madrid, Spain. 8-9/06/2022
Patents